Location: Greenwich, CT
CIK: 0001856083 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value: $3.153B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ARGX | ARGENX SE | 365,000 | $198M | 6.3% | $392.83 | — | SPONSORED ADR | 04016X101 |
| — | DYNAVAX TECHNOLOGIES CORP | 12,526,486 | $140M | 4.4% | $11.00 | — | COM NEW | 268158201 |
| GH | GUARDANT HEALTH INC | 6,000,560 | $138M | 4.4% | $29.46 | -3.9% | COM | 40131M109 |
| APLS | APELLIS PHARMACEUTICALS INC | 4,400,654 | $127M | 4.0% | $45.92 | -19.3% | COM | 03753U106 |
| IMVT | IMMUNOVANT INC | 4,347,464 | $124M | 3.9% | $26.33 | +12.0% | COM | 45258J102 |
| — | SPRINGWORKS THERAPEUTICS INC | 3,843,900 | $123M | 3.9% | $29.46 | — | COM | 85205L107 |
| DYN | DYNE THERAPEUTICS INC | 3,282,000 | $118M | 3.7% | $18.01 | +121.0% | COM | 26818M108 |
| — | INTRA-CELLULAR THERAPIES INC | 1,600,693 | $117M | 3.7% | $54.45 | — | COM | 46116X101 |
| OCUL | OCULAR THERAPEUTIX INC | 12,721,460 | $111M | 3.5% | $4.09 | +101.4% | COM | 67576A100 |
| NTLA | INTELLIA THERAPEUTICS INC | 4,950,000 | $102M | 3.2% | $33.84 | -31.9% | COM | 45826J105 |
| ALKS | ALKERMES PLC | 3,500,000 | $97.97M | 3.1% | $27.60 | -3.4% | SHS | G01767105 |
| — | VERONA PHARMA PLC | 3,180,025 | $91.49M | 2.9% | $12.51 | — | SPONSORED ADS | 925050106 |
| IONS | IONIS PHARMACEUTICALS INC | 2,200,000 | $88.13M | 2.8% | $41.01 | +13.4% | COM | 462222100 |
| NRIX | NURIX THERAPEUTICS INC | 3,868,104 | $86.92M | 2.8% | $12.26 | +84.8% | COM | 67080M103 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,750,945 | $85.33M | 2.7% | $17.78 | -8.1% | COM | 92790C104 |
| BCYC | BICYCLE THERAPEUTICS PLC | 3,548,001 | $80.29M | 2.5% | $36.40 | — | SPONSORED ADS | 088786108 |
| MBX | MBX BIOSCIENCES INC | 3,018,935 | $78.43M | 2.5% | $22.87 | 0.0% | COM | 55287L101 |
| AXSM | AXSOME THERAPEUTICS INC | 857,219 | $77.04M | 2.4% | $75.87 | +15.0% | COM | 05464T104 |
| PLRX | PLIANT THERAPEUTICS INC | 5,972,257 | $66.95M | 2.1% | $21.52 | -41.9% | COM | 729139105 |
| APGE | APOGEE THERAPEUTICS INC | 1,000,000 | $58.74M | 1.9% | $22.03 | +117.5% | COM | 03770N101 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 15,272,172 | $55.44M | 1.8% | $2.90 | — | SPON ADS | 05280R100 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,220,508 | $53.57M | 1.7% | $39.78 | — | SPONSORED ADS | 86366E106 |
| OLMA | OLEMA PHARMACEUTICALS INC | 4,000,000 | $47.76M | 1.5% | $11.20 | +14.2% | COM | 68062P106 |
| TERN | TERNS PHARMACEUTICALS INC | 5,576,558 | $46.51M | 1.5% | $7.29 | +12.9% | COM | 880881107 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,096,452 | $44.28M | 1.4% | $21.92 | -24.3% | COM | 35104E100 |
| ABVX | ABIVAX SA | 3,579,209 | $41.23M | 1.3% | $10.70 | — | SPONSORED ADS | 00370M103 |
| TGTX | TG THERAPEUTICS INC | 1,725,000 | $40.35M | 1.3% | $15.96 | +36.9% | COM | 88322Q108 |
| — | MIND MEDICINE MINDMED INC | 7,065,099 | $40.2M | 1.3% | $8.90 | — | COM NEW | 60255C885 |
| KURA | KURA ONCOLOGY INC | 1,963,505 | $38.37M | 1.2% | $20.32 | -0.3% | COM | 50127T109 |
| GERN | GERON CORP | 7,575,049 | $34.39M | 1.1% | $2.57 | +76.9% | COM | 374163103 |
| CYTK | CYTOKINETICS INC | 629,906 | $33.26M | 1.1% | $56.71 | -1.7% | COM NEW | 23282W605 |
| ORKA | ORUKA THERAPEUTICS INC | 1,235,187 | $30.27M | 1.0% | $34.79 | 0.0% | COM | 687604108 |
| ANIP | ANI PHARMACEUTICALS INC | 504,828 | $30.12M | 1.0% | $52.02 | +17.3% | COM | 00182C103 |
| SYRE | SPYRE THERAPEUTICS INC | 1,000,000 | $29.41M | 0.9% | $19.95 | +39.6% | COM NEW | 00773J202 |
| EWTX | EDGEWISE THERAPEUTICS INC | 1,100,536 | $29.37M | 0.9% | $19.48 | +2.1% | COM | 28036F105 |
| KYMR | KYMERA THERAPEUTICS INC | 600,326 | $28.41M | 0.9% | $35.60 | +24.1% | COM | 501575104 |
| KRRO | KORRO BIO INC | 850,000 | $28.41M | 0.9% | $54.02 | -22.1% | COM | 500946108 |
| RNAM | AVIDITY BIOSCIENCES INC | 475,000 | $21.82M | 0.7% | $43.40 | 0.0% | COM | 05370A108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,350,000 | $21.59M | 0.7% | $15.99 | — | SPONSORED ADS | 152309100 |
| ALEC | ALECTOR INC | 4,631,998 | $21.59M | 0.7% | $6.28 | -14.6% | COM | 014442107 |
| — | NEKTAR THERAPEUTICS | 15,922,655 | $20.7M | 0.7% | $0.59 | — | COM | 640268108 |
| — | 89BIO INC | 2,766,512 | $20.47M | 0.6% | $7.91 | — | COM | 282559103 |
| BCAX | BICARA THERAPEUTICS INC | 796,852 | $20.3M | 0.6% | $25.50 | 0.0% | COM | 055477103 |
| — | AKERO THERAPEUTICS INC | 689,784 | $19.79M | 0.6% | $28.69 | — | COM | 00973Y108 |
| FATE | FATE THERAPEUTICS INC | 5,572,607 | $19.5M | 0.6% | $6.19 | -37.1% | COM | 31189P102 |
| SLN | SILENCE THERAPEUTICS PLC | 1,000,000 | $18.18M | 0.6% | $16.79 | — | ADS | 82686Q101 |
| AXSM | AXSOME THERAPEUTICS INC | 200,000 | $17.97M | 0.6% | $75.87 | +15.0% | Call | 05464T104 |
| ENGN | ENGENE HOLDINGS INC | 2,607,633 | $17.21M | 0.5% | $11.58 | -35.8% | COM | 29286M105 |
| EDIT | EDITAS MEDICINE INC | 4,900,334 | $16.71M | 0.5% | $8.41 | -48.2% | COM | 28106W103 |
| XNCR | XENCOR INC | 800,000 | $16.09M | 0.5% | $18.77 | 0.0% | COM | 98401F105 |
| PYXS | PYXIS ONCOLOGY INC | 4,184,100 | $15.36M | 0.5% | $4.21 | -16.8% | COMMON STOCK | 747324101 |
| CNTX | CONTEXT THERAPEUTICS INC | 7,419,355 | $14.54M | 0.5% | $1.72 | +28.7% | COM | 21077P108 |
| HELP | CYBIN INC | 1,529,987 | $13.6M | 0.4% | $9.89 | 0.0% | COM NEW | 23256X407 |
| ZURA | ZURA BIO LTD | 3,283,783 | $13.33M | 0.4% | $7.12 | -47.5% | CLASS A ORD SHS | G9TY5A101 |
| IVVD | INVIVYD INC | 10,953,937 | $11.17M | 0.4% | $4.13 | -73.8% | COM | 00534A102 |
| CLYM | ELIEM THERAPEUTICS INC | 2,169,143 | $11.04M | 0.4% | $6.66 | +6.3% | COM | 28658R106 |
| INO | INOVIO PHARMACEUTICALS INC | 1,804,366 | $10.43M | 0.3% | $10.52 | -21.6% | COM SHS | 45773H409 |
| AVTX | AVALO THERAPEUTICS INC | 967,000 | $9.187M | 0.3% | $10.31 | 0.0% | COM NEW | 05338F306 |
| NMRA | NEUMORA THERAPEUTICS INC. | 567,428 | $7.496M | 0.2% | $11.66 | 0.0% | COM | 640979100 |
| TVTX | TRAVERE THERAPEUTICS INC | 531,857 | $7.441M | 0.2% | $24.03 | -56.6% | COM | 89422G107 |
| — | VIGIL NEUROSCIENCE INC | 1,553,996 | $5.284M | 0.2% | $5.49 | — | COM | 92673K108 |
| — | REGULUS THERAPEUTICS INC | 3,262,564 | $5.122M | 0.2% | $2.88 | — | COM | 75915K309 |
| — | ALLAKOS INC | 5,000,000 | $3.266M | 0.1% | $2.00 | — | COM | 01671P100 |
| ANRO | ALTO NEUROSCIENCE INC | 219,648 | $2.513M | 0.1% | $15.65 | -21.8% | COM SHS | 02157Q109 |
| NMRA | NEUMORA THERAPEUTICS INC. | 180,500 | $2.384M | 0.1% | $11.66 | 0.0% | Call | 640979100 |
| PRTA | PROTHENA CORP PLC | 140,000 | $2.342M | 0.1% | $21.50 | 0.0% | SHS | G72800108 |
| RLMD | RELMADA THERAPEUTICS INC | 674,833 | $2.186M | 0.1% | $10.86 | -70.2% | COM | 75955J402 |
| ALGS | ALIGOS THERAPEUTICS INC | 244,110 | $2.114M | 0.1% | $12.44 | 0.0% | COM NEW | 01626L204 |
| SYRS | SYROS PHARMACEUTICALS INC | 828,485 | $1.781M | 0.1% | $3.74 | -4.0% | COM NEW | 87184Q206 |
| MGX | METAGENOMI INC | 307,500 | $667K | 0.0% | $11.50 | -69.8% | COM | 59102M104 |
| SRRK | SCHOLAR ROCK HLDG CORP | 48,100 | $385K | 0.0% | $10.43 | -15.8% | COM | 80706P103 |